Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers

Fig. 3

Reactivity of antiphospholipid (aPL) human monoclonal antibody RR7F with PL and PL-binding proteins by line immunoassay (LIA): RR7F (10.0 mg/L) was run in the LIA alone or together with serum, beta2 glycoprotein I (aß2GPI), blood donor serum, and bovine serum albumin (BSA). As positive reaction control a mixture of human IgG and IgM was immobilized. 1, 10.0 mg/L RR7F; 2, 10.0 mg/L RR7F + 10 mg/L ß2GPI; 3, 10.0 mg/L RR7F + 10 mg/L BSA; 4, 10.0 mg/L RR7F + 30 μL serum (1/33); and 5, 30 μL serum (1/33)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us